Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans

A. Nauck, Michael; Niedereichholz, Ulrich; Ettler, Rainer; J. Holst, Jens; Ørskov, Cathrine; Ritzel, Robert; Schmiegel, Wolff

doi:10.1152/ajpendo.1997.273.5.e981

Public

Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans

Published in American Journal of Physiology-Endocrinology and Metabolism • Nov 1, 1997

Authors:

Michael A. Nauck

Ulrich Niedereichholz

Rainer Ettler

Abstract

Glucagon-like peptide 1 (GLP-1) has been shown to inhibit gastric emptying of liquid meals in type 2 diabetic patients. It was the aim of the present study to compare the action of physiological and pharmacological doses of intravenous GLP-1-(7-36) amide and GLP-1-(7-37) on gastric emptying in norma...

Subject

Gastric emptying

Glucagon-like peptide-1

Internal medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!